Do you want to read an article? Please log in or register.
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial
Stroke
RECOMMENDED
Related content
Stroke
Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial
Stroke.
Ntaios G, Pearce LA, Meseguer E, Endres M, Amarenco P, Ozturk S, Lang W, Bornstein NM, Molina CA, Pagola J, Mundl H, Berkowitz SD, Liu YY, Sen S, Connolly SJ, Hart RG, NAVIGATE ESUS Investigators.
doi: 10.1161/STROKEAHA.
Stroke
Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS Trial
Stroke.
Mikulík R, Eckstein J, Pearce LA, Mundl H, Rudilosso S, Olavarría VV, Shoamanesh A, Chamorro Á, Martí-Fàbregas J, Veltkamp R, Öztürk Ş, Tatlisumak T, Peacock WF, Berkowitz SD, Connolly SJ, Hart RG
doi: 10.1161/STROKEAHA.
RECOMMENDED
Stroke
Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis
Stroke.
Ntaios G, Swaminathan B, Berkowitz SD, Gagliardi RJ, Lang W, Siegler JE, Lavados P, Mundl H, Bornstein N, Meseguer E, Amarenco P, Cucchiara B, Camps-Renom P, Makaritsis K, Korompoki E, Papavasileiou V, Marti-Fabregas J, Milionis H, Vemmos K, Connolly SJ, Hart RG, NAVIGATE ESUS Investigators.
doi: 10.1161/
RECOMMENDED
Stroke
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
doi: 10.1161/STROKEAHA.119.028643.
RECOMMENDED
Stroke
Tailoring the Approach to Embolic Stroke of Undetermined Source: A Review
JAMA Neurol.
Kamel H, Merkler AE, Iadecola C, Gupta A, Navi BB
doi: 10.1001/jamaneurol.
Stroke
Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration
Stroke
Hankey GJ, Hackett ML, Almeida OP, Flicker L, Mead GE, Dennis MS, Etherton-Beer C, Ford AH, Billot L, Jan S, Lung T, Lundström E, Sunnerhagen KS, Anderson CS, Thang-Nguyen H, Gommans J, Yi Q, AFFINITY Trial Collaboration.
doi: 10.1161/STROKEAHA.120.033070
COMMENTED
Stroke
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
Lancet.
FOCUS Trial Collaboration
doi: 10.1016/S0140-
RECOMMENDED
Stroke
Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial
JAMA Neurol.
Sarraj A, Mlynash M, Savitz SI, Heit JJ, Lansberg MG, Marks MP, Albers GW
doi: 10.1001/jamaneurol.
Stroke
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial
JAMA.
Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL, Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators.
doi: 10.1001/jama.2019.9346.